Related Experiment Videos
Voltage-dependent nitrendipine binding to cardiac sarcolemmal vesicles
Molecular Pharmacology
|August 1, 1987
Summary
Membrane potential significantly influences calcium channel antagonist binding. Higher membrane potential increases high-affinity binding sites for [3H]nitrendipine in cardiac sarcolemmal vesicles.
Area of Science:
- Cardiovascular Physiology
- Membrane Biophysics
- Pharmacology
Background:
- Cardiac sarcolemmal vesicles are crucial for studying ion channel function.
- Calcium channel antagonists play a vital role in cardiovascular medicine.
- Membrane potential is a key determinant of ion channel activity.
Purpose of the Study:
- To investigate the effect of membrane potential on the binding of [3H]nitrendipine to bovine cardiac sarcolemmal vesicles.
- To determine if changes in membrane potential alter the affinity or number of binding sites for calcium channel antagonists.
Main Methods:
- Purified bovine cardiac sarcolemmal vesicles were used.
- Membrane potential was manipulated by varying external potassium concentrations and using N-methyl-D-glucamine or choline as substitutes.
- [3H]tetraphenylphosphonium was employed to quantify membrane potential.
- Equilibrium binding studies were performed using [3H]nitrendipine.
Main Results:
- Depolarized membrane potentials (0 mV) showed a significant increase (24.7% with NMG, 19.0% with choline) in high-affinity [3H]nitrendipine binding sites compared to hyperpolarized potentials (-40 to -50 mV).
- The dissociation constant (Kd) for [3H]nitrendipine binding remained unchanged across different membrane potentials.
- Graded changes in [3H]nitrendipine binding correlated with changes in membrane potential, supporting its role.
Conclusions:
- Membrane potential directly influences the number of high-affinity binding sites for the calcium channel antagonist [3H]nitrendipine.
- The observed effect is primarily attributed to alterations in membrane potential, not changes in vesicle composition.
- These findings have implications for understanding calcium channel pharmacology in different physiological states.